Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial
Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check43 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check65 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check94 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.